Taking the time to educate patients before their medical device implantation has positive implications for patients, healthcare providers, and medical device manufacturers, according to a new poll.
Taking the time to educate patients before their medical device implantation has positive implications for patients, healthcare providers, and medical device manufacturers, according to a new poll.
Gallup asked patients to rate their level of agreement with 3 statements:
These 3 important aspects of pre-surgery education substantially affected outcomes. Patients who strongly agreed with just 1 statement had higher satisfaction and lower problem incidence. Agreeing with 2 or 3 statements yielded even greater outcomes.
“The vital finding that healthcare providers should heed is that taking the time to educate patients before a procedure has significant consequences for patients, their friends and families, and their community,” wrote Gallup’s Mike Ellrich and Daniela Yu. “But before healthcare leaders take action to improve patient education and communication, they need to know where the biggest gaps exist in these areas.”
Only 37% of respondents who had received a medical implant strongly agreed with all 3 aspects of patient education and 17% agreed with none of them. Less than half of respondents agreed with the statements “I knew what to expect after surgery” and “I was prepared for my experience post-surgery.”
Based on the responses, Gallup determined that patients take care of their part, but that tailored pre-surgery communication with the patient is necessary for successful post-procedure outcomes.
“Though there is room for improving patient education across the board, hospital leaders could enhance patient outcomes by reassessing their education strategy and messages for these key patient segments,” the authors wrote.
Recommendations for how healthcare leaders can improve patient education include:
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
With Hidradenitis Suppurativa, Maternal and Offspring Outcomes May Suffer
October 31st 2024Novel evidence has emerged from a 16-year study that hidradenitis suppurativa can elevate risks of not only pregnancy and postpartum complications, but of morbidity—particularly metabolic- and immunology-related morbidity—for mother and child in the long term.
Read More